Advance of Mesenchymal Stem Cells in Chronic End-Stage Liver Disease Control

Figure 2

Treatments for end-stage liver diseases. The proportion of MSC-based cell therapy clinical trials compared with other conventional trials in liver fibrosis/cirrhosis.